Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB1-cannabinoid receptor involvement

Psychopharmacology

Volumn 190, Issue 4, 2007, Pages 441-448

  Braida, Daniela ^a   Limonta, Valeria ^a   Pegorini, Simona ^a   Zani, Alessia ^a   Guerini Rocco, Chiara ^a   Gori, Enzo ^a   Sala, Mariaelvina ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Conditioned place preference; Nor binalthorphimine; Salvia divinorum; SR 141716A; Swimming behavior; Zebrafish

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; NORBINALTORPHIMINE; RIMONABANT; SALVINORIN A;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSION; CONTROLLED STUDY; DEPRESSION; HALLUCINATION; MOTOR ACTIVITY; NONHUMAN; OBSERVATION UNIT; PLACE PREFERENCE; PRIORITY JOURNAL; REINFORCEMENT; REWARD; SWIMMING; ZEBRA FISH;

ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DITERPENES; DITERPENES, CLERODANE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALLUCINOGENS; MODELS, ANIMAL; MOTOR ACTIVITY; NALTREXONE; NARCOTIC ANTAGONISTS; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTORS, OPIOID, KAPPA; REINFORCEMENT (PSYCHOLOGY); REPRODUCIBILITY OF RESULTS; REWARD; SWIMMING; TIME FACTORS; ZEBRAFISH;

EID: 33846799142     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0639-1     Document Type: Article

References (53)

1. Abramson Ha, Evans LT (1954) Lysergic acid diethylamide (LSD 25) II. Psychobiological effects on the Siamese fighting fish. Science 120:990-991
2. Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315-348
3. Anichtchik OV, Kaslin J, Peitsaro N, Scheinin M, Panula P (2004) Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. J Neurochem 88:443-453
4. Bals-Kubik R, Herz A, Shippenberg TS (1989) Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology 98:203-206
5. Braida D, Iosue S, Pegorini S, Sala M (2004) Delta9-tetrahydrocannabinol- induced conditioned place preference and intracerebroventricular self-administration in rats. Eur J Pharmacol 506:63-69 (erratum in Eur J Pharmacol 511:75-76)
6. Bretaud S, Lee S, Guo S (2004) Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol Teratol 26:857-864
7. Bucheler R, Gleiter CH, Schwoerer P, Gaertner I (2005) Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage). Pharmacopsychiatry 38:1-5
8. Busse GD, Lawrence ET, Riley AL (2004) The modulation of cocaine-induced conditioned place preference by alcohol: effects of cocaine dose. Prog Neuro-Psychopharmacol Biol Psychiatry 28:149-155
9. Butelman ER, Harris TJ, Kreek MJ (2004) The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology 172:220-224
10. Carlezon WA Jr, Beguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM (2006) Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440-447
11. Carroll FI, Harris LS, Aceto MD (2005) Effects of JDTic, a selective kappa-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model. Eur J Pharmacol 524:89-94
12. Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA, Hufeisen SJ, Roth BL (2004) Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations. J Pharmacol Exp Ther 308:1197-1203
13. Clements S, Schreck CB, Larsen DA, Dickhoff WW (2002) Central administration of corticotropin-releasing hormone stimulates locomotor activity in juvenile chinook salmon (Oncorhynchus tshawytscha). Gen Comp Endocrinol 125:319-327
14. Cui CL, Wu LZ, Han JS (2000) Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat. Neurosci Lett 295:45-48
15. Darland T, Dowling JE (2001) Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc Natl Acad Sci USA 98:11691-11696
16. Dlugos CA, Rabin RA (2003) Ethanol effects on three strains of zebrafish: model system for genetic investigations. Pharmacol Biochem Behav 74:471-480
17. Dooley K, Zon LI (2000) Zebrafish: a model system for the study of human disease. Curr Opin Genet Dev 10:252-256
18. Erowid: http://www.erowid.org/ask/ask.cgi?ID=2936
19. Gerlai R, Lahav M, Guo S, Rosenthal A (2000) Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 67:773-782
20. Giacomini NJ, Rose B, Kobayashi K, Guo S (2006) Antipsychotics produce locomotor impairment in larval zebrafish. Neurotoxicol Teratol 28:245-250
21. Giroud C, Felber F, Augsburger M, Horisberger B, Rivier L, Mangin P (2000) Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland. Forensic Sci Int 112:143-150
22. Gonzalez-Nuñez V, Barrallo A, Traynor JR, Rodriguez RE (2006) Characterization of opioid-binding sites in zebrafish brain. J Pharmacol Exp Ther 316:900-904
23. Hampson RE, Mu J, Deadwyler SA (2000) Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G (s) proteins in cultured hippocampal neurons. J Neurophysiol 84:2356-2364
24. Iwamoto ET (1989) Characterization of dynorphin A(1-17)-induced place preference in rats. NIDA Res Monogr 95:308-309
25. Lam CS, Rastegar S, Strahle U (2006) Distribution of cannabinoid receptor 1 in the CNS of zebrafish. Neuroscience 138:83-95
26. Levin ED, Chen E (2004) Nicotinic involvement in memory function in zebrafish. Neurotoxicol Teratol 26:731-735
27. Levin ED, Limpuangthip J, Rachakonda T, Peterson M (2006) Timing of nicotine effects on learning in zebrafish. Psychopharmacology 184:547-552
28. Lockwood B, Bjerke S, Kobayashi K, Guo S (2004) Acute effects of alcohol on larval zebrafish: a genetic system for large-scale screening. Pharmacol Biochem Behav 77:647-654
29. McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ (2006) Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacol Biochem Behav 83:109-113
30. Mendizabal V, Zimmer A, Maldonado R (2006) Involvement of kappa/Dynorphin system in WIN 55,212-2 self-Administration in mice. Neuropsychopharmacology 31:1957-1966
31. Mori T, Nomura M, Nagase H, Narita M, Suzuki T (2002) Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats. Psychopharmacology 161:17-22
32. Mowry M, Mosher M, Briner W (2003) Acute physiologic and chronic histologic changes in rats and mice exposed to the unique hallucinogen salvinorin A. J Psychoact Drugs 35:379-382
33. Ninkovic J, Folchert A, Makhankov YV, Neuhauss SC, Sillaber I, Straehle U, Bally-Cuif L (2006) Genetic identification of AChE as a positive modulator of addiction to the psychostimulant D-amphetamine in zebrafish. J Neurobiol 66:463-475
34. Novak CM, Jiang X, Wang C, Teske JA, Kotz CM, Levine JA (2005) Caloric restriction and physical activity in zebrafish (Danio rerio). Neurosci Lett 383:99-104. DOI 10.1016/j. neulet.2005.03.048
35. Rink E, Wullimann MF (2001) The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res 889:316-330
36. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 99:11934-11939
37. Scholz H, Ramond J, Singh CM, Heberlein U (2000) Functional ethanol tolerance in Drosophila. Neuron 28:261-271
38. Sheffler DJ, Roth BL (2003) Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor. Trends Pharmacol Sci 24:107-109
39. Shin JT, Fishman MC (2002) From zebrafish to human: modular medical models. Annu Rev Genom Hum Genet 3:311-340
40. Shippenberg TS, Herz A (1987) Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu-kappa-opioid agonists. Brain Res 436:169-172
41. Siebert DJ (1994) Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol 43:53-56
42. Smith MA, Bryant PA, McClean JM (2003) Social and environmental enrichment enhances sensitivity to the effects of kappa opioids: studies on antinociception, diuresis and conditioned place preference. Pharmacol Biochem Behav 76:93-101
43. Smith PB, Welch SP, Martin BR (1994) Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice. J Pharmacol Exp Ther 268:1381-1387
44. Spanagel R, Almeida OF, Bartl C, Shippenberg TS (1994) Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology 115:121-127
45. Suzuki T, Shiozaki Y, Masukawa Y, Misawa M, Nagase H (1992) The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn J Pharmacol 58:435-442
46. Turner DM (1996) Salvinorin: The psychedelic essence of Salvia divinorum. Panther Press, San Francisco, CA
47. Valdes LJ, Butler WM, Hatfield GM, Paul AG, Koreeda M (1984) Divinorin A: a psychotropic terpenoid and divinorin B from the hallucinogenic Mexican mint Salvia divinorum. J Org Chem 49:4716-4720
48. Valdes LJ 3rd, Diaz JL, Paul AG (1983) Ethnopharmacology of ska Maria Pastora (Salvia divinorum, Epling and Jativa-M.). J Ethnopharmacol 7:287-312
49. Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, Huang P, Li JG, Cowan A, Liu-Chen LY (2005) Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. J Pharmacol Exp Ther 312:220-230. DOI 10.1124/jpet.104.073668
50. Wasson RG (1962) A new Mexican psychotropic drug from the mint family. Bot Mus Leaf Harv Univ 20:77-84
51. Wasson RG (1963) Notes on the present status of ololuiqui and the other hallucinogens of Mexico. Bot Mus Leaf Harv Univ 20:163-193
52. Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ (2005) Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharmacology 179:551-558
53. Zon LI, Peterson RT (2005) In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4:35-44